期刊文献+

大肠癌组织中PIK3CA和PIK3CB的表达及意义 被引量:10

Expression and significance of PIK3CA and PIK3CB in human colorectal carcinoma
下载PDF
导出
摘要 目的观察癌基因PIK3CA、PIK3CB在大肠癌组织中的表达及其相互关系,并分析PIK3CA和PIK3CB的表达对大肠癌患者预后的影响。方法采用免疫组化EnVision法染色并结合图像进行分析,探讨PIK3CA和PIK3CB在大肠癌组织及正常大肠黏膜组织中的表达;应用RT-PCR和Western blot技术分别检测PIK3CA mRNA和PIK3CB mRNA及其相应蛋白的表达;回访125例大肠癌术后患者,生存分析用Kaplan-Meier法,生存曲线用Log-Rank检验。结果在300例大肠癌蜡块组织及正常黏膜组织中,PIK3CA表达的平均光密度值分别为:10.087 9±2.148 7、6.937 6±2.065 3,PIK3CB表达的平均光密度值分别为:15.870 6±2.877 7、8.693 2±2.442 4。PIK3CA和PIK3CB在大肠癌组织中的表达具有相关性(r=0.68,P<0.05);RT-PCR检测结果显示,与正常大肠黏膜组织相比,大肠癌组织中PIK3CA mRNA和PIK3CB mRNA的表达水平均明显升高,且二者表达结果呈正相关(r=0.74,P<0.05);Western blot法检测发现PIK3CA和PIK3CB蛋白表达水平同样升高,二者表达结果呈正相关(r=0.71,P<0.05);生存分析显示PIK3CA和PIK3CB高表达与患者死亡风险具有明显相关性。结论 PIK3CA和PIK3CB在大肠癌组织中高表达,与正常黏膜组织中的表达相比差异较明显,且PIK3CA和PIK3CB在大肠癌的发生、发展中具有协同作用,PIK3CA、PIK3CB高表达亦是大肠癌患者预后相关的因素之一。检测大肠癌患者PIK3CA和PIK3CB的表达对于控制大肠癌的进展、确定大肠癌的靶点治疗及判断预后具有重要意义。 Purpose To investigate the expression and significance of PIK3CA and PIK3CB in human colorectal carcinoma, and study the correlation between expression of PIK3CA and PIK3CB and the prognosis of colorectal carcinoma. Methods Immunohistochemical and image analysis were to detect the expression of PIK3CA and PIK3CB in tumor tissue and normal colorectal mucosa tissue. RT-PCR and Western blot were employed to detect the expression of PIK3CA and PIK3CB. After the follow-up results were obtained for 125 colorectal cancer patients, survival analysis was used by Kaplan-Meier methods and survival curve was examined by Long-Rank test. Results Of 300 cases of colorectal carcinoma and normal colorectal mucosa, average value of light density of PIK3CA was 10. 087 9±2. 148 7 and 6. 937 6 ±2. 065 3, PIK3CB was 15. 870 6±2. 877 7 and 8. 693 2 ±2.442 4 respectively. The expression of PIK3CA and PIK3CB were a linear correlation and the correlation coefficient (r) of them was O. 68. There was a positive correlation between the ex- pression of PIK3CA and PIK3CB in colorectal carcinoma. The expression of PIK3CA and PIK3CB mRNA and protein in tumor tissue were higher than those in normal colorectal mucosa tissue. There was a positive correlation between the expression of PIK3CA and PIK3CB in tumor tissue, and the correlation coefficient (r)of them were 0. 74 and 0. 71 respectively. Kaplan-Meier survival analysis showed that the patients with high PIK3CA expression and high PIK3CB expression in the tumors had a lower survival rate (P 〈 0. 05 ). Conclusion The results suggest that PIK3CA and PIK3CB have a coordinated effect in the carcinogenesis and development in human eoloreetal carcinoma, and further to supply experimental and theoretical guides for controlling the progression of colorectal carcinoma, determining the therapeutic target for colorectal carcinoma and evulating the prognosis of colorectal carcinomas.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2013年第1期18-22,共5页 Chinese Journal of Clinical and Experimental Pathology
基金 山东省科技发展计划项目(2010GSF10259)
关键词 大肠肿瘤 PIK3CA PIK3CB 免疫组织化学 colorectal neoplasms PIK3CA PIK3CB immunohistochemistry
  • 相关文献

参考文献18

  • 1Laurent-Puiq P,Aqostini J,Maley K. Colorectaloncogenesis[J].Bulletin Du Cancer,2010,(11):1311-1321.
  • 2Izycka-Swieszewska E,Brzeskwiniewicz M,Wozniak A. EGFR,PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours[J].Folia Neuro Pathol,2010,(04):238-245.
  • 3Dbouk H A,Backer J M. A beta version of life:p110β takes center stage[J].Oncotarget,2010,(08):729-733.
  • 4Carnero A,Blanco-Aparicio C,Renner O. The PTEN/PI3K/AKT signalling pathway in cancer,therapeutic implications[J].Current Cancer Drug Targets,2008,(03):187-198.doi:10.2174/156800908784293659.
  • 5Yuan T L,Cantley L C. PI3K pathway alterations in cancer:variations on a theme[J].Oncogene,2008,(41):5497-5510.doi:10.1038/onc.2008.245.
  • 6Xing M. Recent advances in molecular biology of thyroid cancer and their clinical implications[J].Otolaryngologic Clinics of North America,2008,(06):1135-1146.
  • 7Zhao L,Vogt P K. Helical domain and kinase domain mutations in p110 of Phosphate-dylinositol 3-kinase induce gain of function by differert mechanisms[J].Proceedings of the National Academy of Sciences(USA),2008,(07):2652-2657.
  • 8Hutti J E,Pfefferle A D,Russell S C. Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation[J].Cancer Research,2012,(13):3260-3269.
  • 9Janku F,Wheler J J,Westin S N. PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations[J].Journal of Clinical Oncology,2012,(08):777-782.
  • 10Agell L,Hernández S,Salido M. PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors,but PIK3CA,BRAF,KRAS and AKT1 mutations are infrequent events[J].Modern Pathology,2011,(03):443-452.

二级参考文献34

  • 1夏曙,于世英.PI3K/Akt信号转导通路在恶性肿瘤中的研究进展[J].肿瘤,2006,26(6):576-578. 被引量:28
  • 2Volinia S , Hiles I, Ormondoryd E,et al. Molecular-cloning, eDNA sequence, and Chromosomal locolization of the human phosphatidylinositol 3-kinase p110 alpha ( PIK3 CA ) gene [ J ]. Genomics, 1994, 23 : 472-479.
  • 3虞积耀主译.世界卫生组织肿瘤分类及诊断标准系列-消化系统肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:132-135.
  • 4Broderick DK, DiC, Parrett TJ, et al. Mutation of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas and medulloblastomas[ J]. Cancer Res,2004,64:5048-5050.
  • 5Garcia RG, Costa AM, Pereira C, et al. Mutation of PIK3 CA gene in anaplastic thyroid cancer[ J ]. Cancer Res ,2005,65 : 10199-10207.
  • 6LiV S,Wong CW, Chan TL,et al. Mutations of PIK3CA in gastric adenocarcinoma [ J ]. BMC Cancer,2005,5 : 29-31.
  • 7Li Zhao, Peter KV. Helical domain and kinase domain mutations in p110 of Phosphate-dylinositol 3-kinase induce gain of function by different mechanisms[ J]. PNAS,2008,2:652-657.
  • 8Rodriguez VP, Warne PH, Dhand R, et al. Phosphatidylinositol-3- OH kinase as a direct target of Ras[ J]. Nature ( Lond), 1994,370: 527 -532.
  • 9Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer[J]. Nat Rev Cancer,2002,2(7) : 489-501.
  • 10Cantley LC. The phosphoinositide 3-kinase pathway [ J ]. Science ( Wash DC ) ,2002,296 : 1655-1657.

共引文献9

同被引文献102

  • 1张晓霞,费军伟,于晓伟,倪劲松,王芯蕊,李荷莲.卵巢癌组织中PI3K的表达及意义[J].吉林大学学报(医学版),2008,34(6):1027-1030. 被引量:5
  • 2于观贞,王杰军,陈颖,倪灿荣,朱明华.转移相关基因nm23和P53及S100A4在晚期胃癌中的表达及与侵袭转移的相关性研究[J].中华胃肠外科杂志,2006,9(2):165-169. 被引量:23
  • 3杨育生,刘斌,邢传平,高自芳,顾立萍,钱震,董亮,苏勤军.胃癌组织中Caveolin-1,nm23及MMP-2的表达及其意义[J].世界华人消化杂志,2007,15(15):1725-1730. 被引量:19
  • 4康皓,洪光祥,王发斌,陈振兵,黄启顺,翁雨雄,李进,郑怀远,陈燕花.先天性巨指畸形的临床治疗[J].中华手外科杂志,2007,23(5):261-262. 被引量:4
  • 5Jemal A,Center MM,DeSantis C,Ward EM.Global patterns of cancer incidence and mortality rates and trends.Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
  • 6Javed MA,Sheel AR,Sheikh AA,Page RD,Rooney PS.Size of metastatic deposits affects prognosis in patients undergoing pulmonary metastectomy for colorectal cancer.Ann R Coll Surg Engl 2014; 96: 32-36.
  • 7Xing M.Recent advances in molecular biology of thyroid cancer and their clinical implications.Otolaryngol Clin North Am 2008; 41: 1135-1146,ix.
  • 8Janku F,Wheler JJ,Westin SN,Moulder SL,Naing A,Tsimberidou AM,Fu S,Falchook GS,Hong DS,Garrido-Laguna I,Luthra R,Lee JJ,Lu KH,Kurzrock R.PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.J Clin Oncol 2012; 30: 777-782.
  • 9Wang LE,Ma H,Hale KS,Yin M,Meyer LA,Liu H,Li J,Lu KH,Hennessy BT,Li X,Spitz MR,Wei Q,Mills GB.Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.J Cancer Res Clin Oncol 2012; 138: 377-385.
  • 10Levine DA,Bogomolniy F,Yee CJ,Lash A,Barakat RR,Borgen PI,Boyd J.Frequent mutation of the PIK3CA gene in ovarian and breast cancers.Clin Cancer Res 2005; 11: 2875-2878.

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部